Skin autofluorescence, a measure for accumulation of advanced glycation end products, positively associates with blood neutrophil and monocyte counts in the general population, and particularly in men with prediabetes.

Advanced glycation end products Cardiovascular disease Monocytes Neutrophils Prediabetes Sex Skin autofluorescence Type 1 diabetes Type 2 diabetes

Journal

Atherosclerosis
ISSN: 1879-1484
Titre abrégé: Atherosclerosis
Pays: Ireland
ID NLM: 0242543

Informations de publication

Date de publication:
31 May 2024
Historique:
received: 01 02 2024
revised: 06 05 2024
accepted: 30 05 2024
medline: 16 6 2024
pubmed: 16 6 2024
entrez: 15 6 2024
Statut: aheadofprint

Résumé

Previous studies have shown that skin autofluorescence (SAF), measured with an advanced glycation end product (AGE) reader, estimates the accumulation of AGEs in tissues. SAF is predictive of incident type 2 diabetes, cardiovascular disease (CVD), and CV mortality in the general population. Studies in diabetic mice have shown that activation of the receptor for AGEs in hematopoietic progenitor cells increases blood neutrophils and monocytes, impairing atherosclerosis regression. We asked whether SAF is associated with blood neutrophil and monocyte counts in the general population, and whether this was moderated by prediabetes, diabetes, and sex. We examined the associations between SAF and blood neutrophil/monocyte counts in participants of the Lifelines cohort (n = 58,923: n = 24,382 men, and n = 34,541 women), a prospective population-based cohort from the North of the Netherlands, employing multivariable regression analyses. SAF positively associated with blood neutrophil and monocyte counts in the whole cohort. The positive association between SAF and monocyte, but not neutrophil, counts was moderated by prediabetes and diabetes. Positive associations between SAF and blood neutrophil and monocyte counts were moderated by male sex. Moreover, three-way interaction analyses revealed that the positive associations between SAF and neutrophil and monocyte counts were moderated by prediabetes, but not diabetes, in male sex. SAF is positively associated with blood neutrophil and monocyte counts in the general population, especially in men with prediabetes. This may contribute to the increased CV risk in men with prediabetes.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Previous studies have shown that skin autofluorescence (SAF), measured with an advanced glycation end product (AGE) reader, estimates the accumulation of AGEs in tissues. SAF is predictive of incident type 2 diabetes, cardiovascular disease (CVD), and CV mortality in the general population. Studies in diabetic mice have shown that activation of the receptor for AGEs in hematopoietic progenitor cells increases blood neutrophils and monocytes, impairing atherosclerosis regression. We asked whether SAF is associated with blood neutrophil and monocyte counts in the general population, and whether this was moderated by prediabetes, diabetes, and sex.
METHODS METHODS
We examined the associations between SAF and blood neutrophil/monocyte counts in participants of the Lifelines cohort (n = 58,923: n = 24,382 men, and n = 34,541 women), a prospective population-based cohort from the North of the Netherlands, employing multivariable regression analyses.
RESULTS RESULTS
SAF positively associated with blood neutrophil and monocyte counts in the whole cohort. The positive association between SAF and monocyte, but not neutrophil, counts was moderated by prediabetes and diabetes. Positive associations between SAF and blood neutrophil and monocyte counts were moderated by male sex. Moreover, three-way interaction analyses revealed that the positive associations between SAF and neutrophil and monocyte counts were moderated by prediabetes, but not diabetes, in male sex.
CONCLUSIONS CONCLUSIONS
SAF is positively associated with blood neutrophil and monocyte counts in the general population, especially in men with prediabetes. This may contribute to the increased CV risk in men with prediabetes.

Identifiants

pubmed: 38878675
pii: S0021-9150(24)00169-2
doi: 10.1016/j.atherosclerosis.2024.117609
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117609

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Anouk G Groenen (AG)

Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Benedek Halmos (B)

Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Isabelle A van Zeventer (IA)

Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Jonas B Salzbrunn (JB)

Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Marianne L Mayer (ML)

Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Nikita D La Rose (ND)

Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Ilja M Nolte (IM)

Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Jan Jacob Schuringa (JJ)

Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Gerwin Huls (G)

Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Marit Westerterp (M)

Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: m.westerterp@umcg.nl.

Classifications MeSH